Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | GLB1 | P16278 | 1/20 | 0.56 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.56 |
| ▸ | CTRC | Q99895 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL901190 | 0.84 | NPC1 (0.78) | NPC1MEN1KMT2AGLB1CTRB1 | |
| SCHEMBL9367894 | 0.84 | NPC1 (0.78) | NPC1MEN1KMT2AGLB1CTRB1 | |
| SCHEMBL901003 | 0.84 | NR1H2 (0.65) | NPC1MEN1KMT2AMAPTNR1H2 | |
| SCHEMBL9367899 | 0.84 | NPC1 (0.78) | NPC1MEN1KMT2AGLB1CTRB1 | |
| SCHEMBL901189 | 0.84 | NPC1 (0.78) | NPC1MEN1KMT2AGLB1CTRB1 | |
| SCHEMBL20547552 | 0.77 | ALDH1A1 (0.63) | NPC1MEN1KMT2AMAPTRAB9A | |
| SCHEMBL6033210 | 0.77 | ALDH1A1 (0.63) | NPC1MEN1KMT2AMAPTRAB9A | |
| SCHEMBL21242225 | 0.76 | NPC1 (0.67) | NPC1MEN1KMT2AGLB1CTRB1 | |
| SCHEMBL12534430 | 0.76 | NPC1 (0.67) | NPC1MEN1KMT2AGLB1CTRB1 | |
| SCHEMBL11673519 | 0.76 | ESR1 (0.65) | NPC1MEN1KMT2AMAPTNR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814346-B1 | Charge transportation in nanostructured functional selenium-containing liquid crystalline materials | King Faisal University (SA) | 2023-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814346-B1 | Charge transportation in nanostructured functional selenium-containing liquid crystalline materials | SLC39A14, SLC39A3, SLC19A2 | NPC1 778/4885MEN1 1771/4885KMT2A 2862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.